フェキサラミン
![]() |
- ¥28300 - ¥805000
- 化學名: フェキサラミン
- 英語名: Fexaramine
- 別名:フェキサラミン;メチル 3-[3-(N-{[4'-(ジメチルアミノ)-[1,1'-ビフェニル]-4-イル]メチル}シクロヘキサネアミド)フェニル]プロパ-2-エノアート;3-[3-[(シクロヘキシルカルボニル)[4′-(ジメチルアミノ)-4-ビフェニリルメチル]アミノ]フェニル]プロペン酸メチル
- CAS番號: 574013-66-4
- 分子式: C32H36N2O3
- 分子量: 496.64
- EINECS:
- MDL Number:MFCD09971007
6物価
選択條件:
ブランド
- 富士フイルム和光純薬株式會社(wako)
- Sigma-Aldrich Japan
パッケージ
- 5mg
- 10mg
- 25mg
- 50mg
- 250mg
- 1g
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01COBQJ-8796
- 製品説明フェキサラミン
- 英語製品説明Fexaramine
- 包裝単位1g
- 価格¥805000
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01TOC2563
- 製品説明
- 英語製品説明Fexaramine
- 包裝単位50mg
- 価格¥342000
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01COBQJ-8796
- 製品説明フェキサラミン
- 英語製品説明Fexaramine
- 包裝単位250mg
- 価格¥320000
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01TOC2563
- 製品説明
- 英語製品説明Fexaramine
- 包裝単位10mg
- 価格¥81000
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號SML1390
- 製品説明 ≥98% (HPLC)
- 英語製品説明Fexaramine ≥98% (HPLC)
- 包裝単位25mg
- 価格¥91100
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號SML1390
- 製品説明 ≥98% (HPLC)
- 英語製品説明Fexaramine ≥98% (HPLC)
- 包裝単位5mg
- 価格¥28300
- 更新しました2024-03-01
- 購入
生産者 | 製品番號 | 製品説明 | 包裝単位 | 価格 | 更新時間 | 購入 |
---|---|---|---|---|---|---|
富士フイルム和光純薬株式會社(wako) | W01COBQJ-8796 | フェキサラミン Fexaramine |
1g | ¥805000 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式會社(wako) | W01TOC2563 | Fexaramine |
50mg | ¥342000 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式會社(wako) | W01COBQJ-8796 | フェキサラミン Fexaramine |
250mg | ¥320000 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式會社(wako) | W01TOC2563 | Fexaramine |
10mg | ¥81000 | 2024-03-01 | 購入 |
Sigma-Aldrich Japan | SML1390 | ≥98% (HPLC) Fexaramine ≥98% (HPLC) |
25mg | ¥91100 | 2024-03-01 | 購入 |
Sigma-Aldrich Japan | SML1390 | ≥98% (HPLC) Fexaramine ≥98% (HPLC) |
5mg | ¥28300 | 2024-03-01 | 購入 |
プロパティ
沸點 :677.7±55.0 °C(Predicted)
比重(密度) :1.158±0.06 g/cm3(Predicted)
貯蔵溫度 :2-8°C
溶解性 :DMSO : 50 mg/mL (100.68 mM; Need ultrasonic)
酸解離定數(shù)(Pka) :4.95±0.24(Predicted)
外見 :powder
色 :white to beige
比重(密度) :1.158±0.06 g/cm3(Predicted)
貯蔵溫度 :2-8°C
溶解性 :DMSO : 50 mg/mL (100.68 mM; Need ultrasonic)
酸解離定數(shù)(Pka) :4.95±0.24(Predicted)
外見 :powder
色 :white to beige
安全情報
絵表示(GHS): |
![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
注意喚起語: | Warning | |||||||||||||||||||||
危険有害性情報: |
|
|||||||||||||||||||||
注意書き: |
|
説明
The farnesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 nesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 nesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 nesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 nesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 nesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 nesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 nesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency compared to the high affinity FXR agonist GW 4064 nesoid X receptor (FXR) is a nuclear receptor that acts as a bile acid sensor, protecting cells and organs against bile acid toxicity and coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Fexaramine is an FXR agonist (EC50 = 25 nM) that demonstrates 100-fold increased affinity to FXR compared to endogenous bile acids and 3-fold increased potency co関連製品価格
5-クロロ-N-[2-メトキシ-4-[4-(4-メチルピペラジノ)ピペリジノ]フェニル]-N′-[2-(イソプロピルスルホニル)フェニル]-2,4-ピリミジンジアミン 3-(3-ブロモ-4-((2,4-ジフルオロベンジル)オキシ)-6-メチル-2-オキソピリジン-1(2H)-イル)-N,4-ジメチルベンズアミド (E)-N-[2-(2-メチル-1H-インドール-1-イル)エチル]-3-(3,4,5-トリメトキシフェニル)プロペンアミド N5,N6-ビス(2-フルオロフェニル)-[1,2,5]オキサジアゾロ[3,4-b]ピラジン-5,6-ジアミン 3-[[(4-クロロベンジル)(5-ニトロチオフェン-2-イルメチル)アミノ]メチル]ピロリジン-1-カルボン酸エチル